



Markets
/
Stocks
/
nasdaq-tmo
/

Thermo Fisher Scientific Inc

TMO

View Detailed Chart

489.060USD

-8.540-1.71%

Close 04/02, 16:00（ET）Quotes delayed by 15 min

186.22BMarket Cap

29.39P/E TTM



Thermo Fisher Scientific Inc

489.060

-8.540-1.71%

Company

Intraday

30m

Today

-1.71%

5 Days

-4.76%

1 Month

-7.54%

6 Months

-20.18%

Year to Date

-5.99%

1 Year

-14.43%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 32 analysts

BUY

Current Rating

657.328

Target Price

36.10%

Rising Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Thermo Fisher Scientific Inc

TMO

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Danaher Corp

DHR

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(10)

Neutral(1)

Buy(1)

Indicators

Sell(4)

Neutral(1)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-4.510

Sell

RSI(14)

31.272

Neutral

STOCH(KDJ)(9,3,3)

16.682

Oversold

ATR(14)

11.006

Low Volatility

CCI(14)

-158.871

Sell

Williams %R

79.621

Sell

TRIX(12,20)

-0.256

Sell

StochRSI(14)

44.575

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

496.193

Sell

MA10

506.475

Sell

MA20

513.409

Sell

MA50

537.677

Sell

MA100

535.064

Sell

MA200

560.773

Sell

News

Thermo Fisher Scientific To Acquire Solventum’S Purification And Filtration Business

Feb 25 (Reuters) - Thermo Fisher Scientific Inc TMO.N:THERMO FISHER SCIENTIFIC TO ACQUIRE SOLVENTUM’S PURIFICATION AND FILTRATION BUSINESSTHERMO FISHER SCIENTIFIC INC - TO ACQUIRE SOLVENTUM'S PURIFICATION & FILTRATION BUSINESS FOR $4.1 BILLIONTHERMO FISHER SCIENTIFIC INC - TRANSACTION EXPECT...

ReutersTue, Feb 25

Thermo Fisher Scientific Inc reports results for the quarter ended December 31 - Earnings Summary

Thermo Fisher Scientific Inc TMO.N reported quarterly adjusted earnings of $6.10 per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $5.67. The mean expectation of twenty five analysts for the quarter was for earnings of $5.94...

ReutersThu, Jan 30

Company

Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, the Company provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, the Company provides an offering of instruments and the supporting consumables, software and services that are used for a range of applications. The Company’s Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories.

Company codeTMO

CompanyThermo Fisher Scientific Inc

CEOMr. Marc N. Casper

Websitehttps://www.thermofisher.com/